A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
May 15, 2012
112th Congress, 2011–2013
Enacted — Signed by the President on Jul 9, 2012
This bill was enacted after being signed by the President on July 9, 2012.
Senator from Iowa
Read Text »
Last Updated: Jun 27, 2012
Length: 140 pages
This bill incorporates provisions from:
S. 2516: Food and Drug Administration Safety and Innovation Act
Ordered Reported on May 7, 2012. 69% incorporated. (compare text)
H.R. 5651: Food and Drug Administration Reform Act of 2012
Passed House (Senate next) on May 30, 2012. 61% incorporated. (compare text)
H.R. 3988: Generic Drug and Biosimilar User Fee Act of 2012
Introduced on Feb 8, 2012. 92% incorporated. (compare text)
S. 2289: Better Pharmaceuticals and Devices for Children Act of 2012
Introduced on Apr 17, 2012. 47% incorporated. (compare text)
S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments
Introduced on Feb 15, 2012. 34% incorporated. (compare text)
H.R. 5334: To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.
Introduced on May 7, 2012. 80% incorporated. (compare text)
H.R. 2182: Generating Antibiotic Incentives Now Act of 2011
Introduced on Jun 15, 2011. 18% incorporated. (compare text)
S. 1734: Generating Antibiotic Incentives Now Act of 2011
Introduced on Oct 19, 2011. 18% incorporated. (compare text)
H.R. 3205: FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Introduced on Oct 14, 2011. 18% incorporated. (compare text)
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
Passed Senate (House next)
The bill was passed in a vote in the Senate. It goes to the House next.
Source Bill — Passed House (Senate next)
This activity took place on a related bill, H.R. 5651 (112th), possibly in lieu of similar activity on S. 3187 (112th).
Passed House with Changes (back to Senate)
The House passed the bill with changes not in the Senate version and sent it back to the Senate to approve the changes. The vote was by voice vote so no record of individual votes was made.
Senate Agreed to Changes
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.
Enacted — Signed by the President
The President signed the bill and it became law.
S. 3187 (112th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act. Retrieved from https://www.govtrack.us/congress/bills/112/s3187
“S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act.” www.GovTrack.us. 2012. July 26, 2017 <https://www.govtrack.us/congress/bills/112/s3187>
|title=S. 3187 (112th)
|accessdate=July 26, 2017
|author=112th Congress (2012)
|date=May 15, 2012
|quote=Food and Drug Administration Safety and Innovation Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.